Investor Relations

Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company committed to developing and delivering life-changing treatments for orphan diseases.

Stock Quote

Price / Change

22.97

0.25

Ticker:
HPTX
Exchange:
NASDAQ
Day High:
23.04
Day Low:
22.50
Volume:
591,100

4:00 PM ET on December 19, 2014
Delayed at least 20 minutes.
Provided by eSignal.